Pharmacokinetic modeling of in-feed tetracyclines in pigs using a meta-analytic compartmental approach

Journal of Swine Health and Production

Volumn 6, Issue 5, 1998, Pages 189-202

  Del Castillo, Jerome R E ^a   Elsener, Johanne ^b   Martineau, Guy P ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Ayerst Laboratories Inc

Author keywords

Antibiotics; Chlortetracycline; Feeding behavior; In feed; Meta analysis; Oxytetracycline; Pharmacokinetics

Indexed keywords

EID: 3142527059     PISSN: 1537209X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Pijpers A, Schoevers EJ, van Gogh H, van Leengoed LAMG, Visser IJR, van Miert ASJPAM, Verheijden JHM. The influence of disease on feed and water consumption and on pharmacokinetics of orally administered oxytetracycline in pigs. J Anim Sci. 1991;69:2947-2954.
2. Keck G, Borne PM. Nouvelles conceptions en antibiothérapie et leurs applications pratiques en médecine vétérinaire. Revue Med Vet. 1995;146:309-320.
3. Wages D. Volumetric versus mg/kg dosing in poultry. Proc 44th N Cent Avian Dis Conf Symp Poultry Ther. 1993; Columbus Ohio: 22-24.
4. Sutter HM, Wanner M. Futterzubereitung und pharmacokinetik von chlortetracyclin beim ferkel. Schweitz Arch Tierheilk., 1990;132:175-181.
5. Gibaldi M. Gastrointestinal absorption - Biologic considerations. In: Gibaldi M, ed. Biopharmaceutics and Clinical Pharmacokinetics, 4th ed. Malvern, Pennsylvania: Lea & Febiger. 1991; 24-39.
6. Wanner M, Walker W, Sutter HM, Riond JL, Broz J. Influence of dietary citric acid and calcium on the bioavailability of orally administered chlortetracyclin in piglets. J Vet Med. 1991;38:755-762.
7. National Research Council. Nutrient Requirements of Swine. 9th rev ed. Washington DC: National Academy Press. 1988;50.
8. Labroue F, Guéblez R, Marion M, Sellier P. Influence de la race sur le comportement alimentaire de porcs en croissance élevés en groupe. Journ Recherche Porcine en France. 1995;27:175-182.
9. Henry Y, Perez JM, Seve B. Alimentation des porcs en croissance. In: Blum JC, ed. L'alimentation des Animaux Monogastriques. Paris, France: I.N.R.A. 1984;49-66.
10. Nielsen BL, Lawrence AB. The effect of group size on the behaviour and performance of growing pigs using computerised single-space feeders. Pig News and Info. 1993;14:127N-129N.
11. Holford NHG, Sheiner LB. Kinetics of pharmacologic response. Pharmacol Ther. 1982;16:143-166.
12. Kilroy CR, Hall WF, Bane DP, Bevill RF, Koritz GD. Chlortetracycline in swine - bioavailability and pharmacokinetics in fasted and fed pigs. J Vet Pharmacol Ther. 1990;13:49-58.
13. Wanner M, Nietlispach G, Sutter HM. Einfluß von citronensaüre une calcium auf die bioverfügbarkeit oral verabreichten oxytetracyclins beim ferkel. Dtsch Tierärztl Wschr. 1990;97:515-518.
14. Dickersin K, Berlin JA. Meta-analysis: State-of-the-science. Epidemiol Rev. 1992;14:154-176.
15. Gibaldi M. Introduction to pharmacokinetics. In. Giabaldi M, ed. Biopharmaceutics and Clinical Pharmacokinetics. 4th ed. Philadelphia, Pennsylvania: Lea and Febiger. 1991.
16. Yamaoka K, Nakagawa T, Uno T. Statistical moments in pharmacokinetics. J Pharmacokinet Biopharm. 1978;6:547-58.
17. Asanuma K, Shimazaki S, Hirata K. A study concerning the distribution of OTC and CTC in the lung and blood of pigs. J Anim Drugs - Getsukan Doyaku. 1984;6:1-14.
18. Andrews JJ, Lucas TE, Johnson DD. Prevention and control of experimentally induced Pasteurella multocida pneumonia in swine by the use of chlortetracycline administered in feed. Agri-Practice. 1988;9:33-38.
19. Daniel W. Procedures that utilize data from two independent samples. In: Daniel WW, ed. Applied Nonparametric Statistic. 2nd ed. Boston, Massachusetts: PWS-Kent Publishing Co. 1990.82-143.
20. Rowland M, Tozer TN. Clinical Pharmacokinetics: Concepts and Applications. Third ed; Media, Pennsylvania: Williams and Wilkins. 1994.
21. Gibaldi M. Method of Superposition, in Gibaldi M, ed. Biopharmaceutics and Clinical Pharmacokinetics. 4th ed. Malvern, Pennsylvania: Lea and Febiger. 1991; p. 379.
22. Black SD, Gentry RD. The distribution of oxytetracycline in the tissues of swine following a single oral dose. Can Vet J. 1984;25:158-161.
23. Mevius DJ, Vellenga L, Breukink HJ, Nouws JFM, Vree TB, Driessens F. Pharmacokinetics and renal clearance of oxytetracycline in piglets following intravenous and oral administration. Vet Quart. 1986;8:274-284.
24. Reichert J. Blutspiegel von chlor- und oxytetracyclin beim ferkel nach futter- oder wasser-medication bei unterschiedlicher fütterungstechnik (MSc diss). Zurich, Switzerland:University of Zurich. 1988; 123 p.
25. Hall WF, Kniffen TS, Bane DP, Bevill RF, Koritz GD. Plasma concentrations of oxytetracyline in swine after administration of the drug intramuscularly and orally in feed. JAVMA. 1989;194:1265-1268.
26. Hunneman M, Pijpers A, Lommerse J, Crauwels APP, Verheijden JHM. Prophylaxis of pleuropneumonia in pigs by in-feed medication with oxytetracycline and the subsequent transmission of infection. Vet Rec. 1994;134:215-218.
27. Pijpers A, Schoevers EJ, Haagsma N, Verheijden JHM. Plasma levels of OTC, DC, and MC in pigs after oral administration in-feed. J Anim Sci. 1991;69:4512-4522.
28. del Castillo J, 1997; unpublished observations.
29. Luthman J, Jacobsson SO, Bengtsson B, and Korpe C. Studies on the bioavailability of tetracycline chloride after oral administration to calves and pigs. J Vet Med. 1989. Series A, 36:261-268.
30. Craig WA, Suh B. Theory and practical impact of binding of antimicrobials to serum proteins and tissue. Scand J Infect Dis. Suppl. 1978;14:92-99.
31. Scheife RT. Protein binding: What does it mean? Drug Intell Clin Pharm. 1989;23:S27-S31.
32. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility tests. 4th edition; approved. Villanova, Pennsylvania: NCCLS document M2-A4. 1990.
33. Messier S, Higgins R, Nadeau M. À propos des épreuves de sensibilité pour Actinobacillus pleuropneumoniae. Med Vet Québec. 1993;23:127-129.
34. Elsener J, del Castillo JRE, Martineau GP. MIC interpretation: Flaws behind the scene. SHAP. Submitted for publication.
35. Hannan PCT, O'Hanlon PJ, Rogers Nil. In vitro evaluation of various quinolone antibacterial agents against veterinary mycoplasmas and porcine respiratory bacterial pathogens. Res Vet Sci. 1989;46:202-211.
36. Pijpers A, van Klingeren B, Schoevers EJ, Verheijden JHM, van Miert ASJPAM. In vitro activity of five tetracyclines and some other antimicrobial agents against four porcine respiratory tract pathogens. J Vet Pharmacol Therap. 1989;12:267-276.
37. Kuwano A, Yamamoto K, Takei M, Kato M, Tachi H. Evaluation of the effect of ofloxacin in experimentally induced mycoplasmal pneumonia in swine. Proc IPVS Cong. 1992; 12:320.
38. Kim BH, Jung BY. Serotypes and antimicrobial susceptibility of Actinobacillus pleuropneumoniae isolated from pneumonic lungs of Korean swine. Proc. IPVS Cong. 1994;13:126.
39. Flaus L, Tan ATSC. Synergy study between lincomycin and oxytetracyclin, and between lincomycin and chlortetracyclin against Actinobacillus pleuropneumoniae and Pasteurella multocida. Proc. IPVS Cong. 1994;13:186.
40. Barigazzi G, Candotti P, Raffo A. Determinazione della minima ccncentrazione inibente (MCI) di 23 farmaci antibatterici nei confronti di 97 ceppi di Haemophilus parasuis isolati dal suino. Atti del XXI Meet Ann della Societa Italiana di Patologia ed Allevamento dei Suini. Montichiari, Italia. 1994; 135-141.
41. Yamamoto K, Koshimizu K. In vitro susceptibility of Mycoplosma hyopneumoniae to antibiotics. Proc. IPVS Cong. 1984;8:116.
42. ter Laak EA, Pijpers A, Noordergraaf JH, Schoevers EC, Verheijden JHM. Comparison of methods for in vitro testing of susceptibility of porcine Mycoplasma species to antimicrobial agents. Antimicrob Agents Chemother. 1991;35:228-233.
43. Cooper AC, Fuller JR, Fuller MK, Whittlestone P, Wise DR. In vitro activity of danofloxacin, tylosin, and oxytetracycline against mycoplasmas of veterinary importance. Res Vet Sci. 1993;54:329-334.
44. del Castillo J. Biodisponibilités orale et parentérale des pénicillines naturelles utilisées en prophylaxie de la streptococci's chez le porcelet sevré (MSc thesis). St-Hyacinthe, Canada:Université de Montŕal. 1995;145pp.
45. Turndidge JD. Prediction of antibiotic dosing intervals from in vitro susceptibility, pharmacokinetics and post-antibiotic effect theoretical considerations. Scand J Inf Dis. 1991;Suppl.74:137-141.
46. Zhanel GG, Hoban DJ, Godfrey KM. The postantibiotic effect A review of in vitro and in vivo data. Drug Intell Clin Pharm. 1991;25:153-163.
47. Gerber AU, Craig WA. Experimentelle studien zur frage des optimalen dosisinteralls in der antibiotikatherapie. Schweitz Med Wschr. 1982;112:42-45.
48. MacKenzie FM, Gould IM. The post-antibiotic effect. J Antimicrob Chemother. 1993;32:519-537.
49. Spivey JM. The postantibiotic effect. Clin Pharm. 1992;11:865-875.